Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1050 of 2873 entries
View as:

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05049538 Org: User:
Start: 06/18/19 End: 06/30/28 Due: 06/30/29

Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01430351 Org: User:
Start: 09/14/11 End: 02/02/25 Due: 02/02/26

Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00038051 Org: User:
Start: 05/31/99 End: 02/28/13 Due: 02/28/14

Outpatient Neutropenic Diet Study

Phase: N/A Priority: Normal
NCT ID: NCT00947648 Org: User:
Start: 07/31/09 End: 03/31/13 Due: 03/31/14

Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC)

Phase: N/A Priority: Normal
NCT ID: NCT01254903 Org: User:
Start: 12/03/10 End: 04/01/27 Due: 04/01/28

EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active

Phase: N/A Priority: Normal
NCT ID: NCT06649058 Org: User:
Start: 02/14/25 End: 09/30/30 Due: 09/30/31

CBCT in Guiding Bronchoscopy in Patients With Lung Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02978170 Org: User:
Start: 11/28/16 End: 05/04/19 Due: 05/04/20

CPX-351 in Treating Patients With Newly Diagnosed, High-Risk Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02286726 Org: User:
Start: 05/04/15 End: 01/22/20 Due: 01/22/21

Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01603212 Org: User:
Start: 07/18/13 End: 07/05/17 Due: 07/05/18

Huachansu & Gemcitabine in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00837239 Org: User:
Start: 06/30/07 End: 07/31/12 Due: 07/31/13

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00429572 Org: User:
Start: 01/31/98 End: 05/31/08 Due: 05/31/09

Inotuzumab Ozogamicin in Treating Patients With Relapsed or Refractory CD22 Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03094611 Org: User:
Start: 11/30/17 End: 03/11/20 Due: 03/11/21

Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00005969 Org: User:
Start: 09/30/99 End: - Due: -

Gliogene: Brain Tumor Linkage Study

Phase: N/A Priority: Normal
NCT ID: NCT00418899 Org: User:
Start: 02/12/04 End: 09/01/22 Due: 09/01/23

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03896568 Org: User:
Start: 02/12/19 End: 09/30/27 Due: 09/30/28

Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations

Phase: N/A Priority: Normal
NCT ID: NCT01531361 Org: User:
Start: 02/06/12 End: 01/13/21 Due: 01/13/22

Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00360672 Org: User:
Start: 01/31/09 End: 05/31/12 Due: 05/31/13

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05144542 Org: User:
Start: 03/07/22 End: 09/30/25 Due: 09/30/26

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03525873 Org: User:
Start: 08/02/18 End: 12/31/26 Due: 12/31/27

Phase II Study of Tesetaxel in Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01064713 Org: User:
Start: 02/28/10 End: 10/31/14 Due: 10/31/15

Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006081 Org: User:
Start: 06/30/00 End: 09/30/05 Due: 09/30/06

Natrecor in Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00075179 Org: User:
Start: 12/31/03 End: 03/28/06 Due: 03/28/07

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Phase: N/A Priority: Normal
NCT ID: NCT00330564 Org: User:
Start: 05/31/06 End: 05/31/11 Due: 05/31/12

A Phase II Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06569368 Org: User:
Start: 07/10/24 End: 10/31/26 Due: 10/31/27

Feasibility of Accelerated, Personalized rTMS as an Adjuvant for Impulse Control Disorders: a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT06639594 Org: User:
Start: 11/21/24 End: 11/03/27 Due: 11/03/28